Glazer Capital LLC’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Glazer Capital LLC’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-67,074	Closed	-$1.43M	–	155
2024 Q1	$1.43M	Buy	+67,074	New	+$802K	0.15%	87

Glazer Capital LLC's FUSN Position: Q2 2024 in Review

Glazer Capital LLC sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 67,074 shares — an estimated $1.43M sold.

Glazer Capital LLC first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $1.43M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Glazer Capital LLC reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Glazer Capital LLC sold 67,074 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $1.43M.
Glazer Capital LLC first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Glazer Capital LLC's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.43M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Glazer Capital LLC's 13F filing for Q2 2024, filed 14 Aug 2024.